Alan Sandler, M.D.

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Alx Oncology Holdings Inc publishes a filing, an earnings call transcript or a press release.

Get ALXO alerts

About Alan Sandler, M.D.

Alan Sandler, M.D. is recorded as Board Member at Alx Oncology Holdings Inc (ALXO) since August 5, 2024. Alx Oncology Holdings Inc reported in an 8-K filed September 12, 2025 that Alan Sandler, M.D. resigned as Chief Medical Officer, effective September 26, 2025. Alx Oncology Holdings Inc reported in an 8-K filed September 12, 2025 that Alan Sandler, M.D. was appointed Class II director, effective September 26, 2025. Alx Oncology Holdings Inc reported in an 8-K filed November 14, 2024 that Alan Sandler, M.D. resigned as member of the Board, effective November 10, 2024. Equibles holds 5 filed executive changes naming Alan Sandler, M.D.; each is listed under recent activity with its source filing. Alx Oncology Holdings Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alx Oncology Holdings Inc includes Jason Lettmann (CEO and Board Member), Scott Garland (Chairman and Board Member), Harish Shantharam (CFO) and 7 others.

“On September 11, 2025, Alan Sandler, M.D., informed the Company of his resignation as Chief Medical Officer of the Company, effective September 26, 2025, in order to pursue other professional opportunities.”

Alx Oncology Holdings Inc Form 8-K, filed September 12, 2025 · Read the filing

“Additionally, on September 11, 2025, the Board agreed to re-appoint Alan Sandler, M.D. to the Board, to serve as a Class II director for a term expiring at the 2028 annual meeting of stockholders, to be effective September 26, 2025.”

Alx Oncology Holdings Inc Form 8-K, filed September 12, 2025 · Read the filing

Affiliation history

Alx Oncology Holdings Inc (ALXO)
SEC 8-K

Current
2024-11-10–present
Alx Oncology Holdings Inc (ALXO)
Board Member

SEC 8-K

Current
2024-08-05–present
Alx Oncology Holdings Inc (ALXO)
Board Member

SEC 8-K

2025-09-26–2024-11-10

Company network

Alx Oncology Holdings Inc

ALXO

Current role

Biotechnology · Healthcare

Board Member

2024-08-05–present

Leadership on record at Alx Oncology Holdings Inc

Jason Lettmann CEO, Board Member
Scott Garland Chairman, Board Member
Harish Shantharam CFO
Michael Listgarten General Counsel
Shelly Wong Chief Accounting Officer
Alan Sandler Board Member
Barbara Klencke Board Member
Chris Takimoto Board Member
Continuing Directors Board Member
Daniel Curran Board Member

Recent activity

Executive change Appointed: Class II director Alx Oncology Holdings Inc (ALXO)
2025-09-26
Executive change Resigned: Chief Medical Officer Alx Oncology Holdings Inc (ALXO)
2025-09-26
Executive change Appointed: Chief Medical Officer Alx Oncology Holdings Inc (ALXO)
2024-11-10
Executive change Resigned: member of the Board Alx Oncology Holdings Inc (ALXO)
2024-11-10
Executive change Appointed: Class III director of the Board of Directors Alx Oncology Holdings Inc (ALXO)
2024-08-05